GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » iDNA Genomics Public Ltd (CYS:IDNA) » Definitions » EPS (Basic)

iDNA Genomics Public (CYS:IDNA) EPS (Basic) : € (TTM As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is iDNA Genomics Public EPS (Basic)?

iDNA Genomics Public's basic earnings per share (Basic EPS) for the six months ended in . 20 was €0.00. iDNA Genomics Public does not have enough years/quarters to calculate its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in . 20.

iDNA Genomics Public's EPS (Diluted) for the six months ended in . 20 was €0.00. iDNA Genomics Public does not have enough years/quarters to calculate its EPS (Diluted) for the trailing twelve months (TTM) ended in . 20.

iDNA Genomics Public's EPS without NRI for the six months ended in . 20 was €0.00. iDNA Genomics Public does not have enough years/quarters to calculate its EPS without NRI for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


iDNA Genomics Public EPS (Basic) Historical Data

The historical data trend for iDNA Genomics Public's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iDNA Genomics Public EPS (Basic) Chart

iDNA Genomics Public Annual Data
Trend
EPS (Basic)

iDNA Genomics Public Semi-Annual Data
EPS (Basic)

iDNA Genomics Public EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

iDNA Genomics Public's Basic EPS for the fiscal year that ended in . 20 is calculated as


iDNA Genomics Public's Basic EPS for the quarter that ended in . 20 is calculated as


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


iDNA Genomics Public  (CYS:IDNA) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


iDNA Genomics Public EPS (Basic) Related Terms

Thank you for viewing the detailed overview of iDNA Genomics Public's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


iDNA Genomics Public Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Evrota 25- 27, Kifissia, GRC, 145 64
iDNA Genomics Public Ltd is engaged in performing precision medicine and genetic analysis (DNA Tests). Its focus is on developing and providing Genetic Testing Analysis both in Medical and Direct-To-Consumer Genomics sectors, with research activity through cooperation with universities in Greece and abroad.

iDNA Genomics Public Headlines